Pin64 - Dolutegravir Plus Lamivudine for the Treatment of Naïve Adults Living With Hiv-1: A Uk Cost-Minimization Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1383
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost Calculation for a Flash Glucose Monitoring System for UK Adults With Type 1 Diabetes Mellitus Receiving Intensive Insulin Treatment

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Clinical Effectiveness of Dolutegravir in the Treatment of HIV/AIDS

Infection and Drug Resistance
Infectious DiseasesPharmacology
2015English

The Prevalence of HIV-1 Drug Resistance Among Antiretroviral Treatment Naïve Individuals in Mainland China: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

The Cost-Effectiveness of Hepatitis C Treatments in Treatment Naïve Genotype 1 Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living With HIV-1

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy